Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells
- 2 August 2007
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 173 (3) , 175-180
- https://doi.org/10.1016/j.toxlet.2007.07.009
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive AgentCancer Epidemiology, Biomarkers & Prevention, 2007
- Resveratrol Protects Against 4-Hydroxynonenal-Induced Apoptosis by Blocking JNK and c-JUN/AP-1 SignalingToxicological Sciences, 2005
- Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer CellsJournal of Clinical Endocrinology & Metabolism, 2005
- Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implicationsMolecular Nutrition & Food Research, 2005
- Local Aromatase Expression in Human Prostate Is Altered in MalignancyJournal of Clinical Endocrinology & Metabolism, 2004
- Anti‐Aromatase Chemicals in Red WineAnnals of the New York Academy of Sciences, 2002
- White Button Mushroom Phytochemicals Inhibit Aromatase Activity and Breast Cancer Cell ProliferationJournal of Nutrition, 2001
- An Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene ExpressionMethods, 2001
- Suppression of aromatase (estrogen synthetase) by red wine phytochemicalsBreast Cancer Research and Treatment, 2001
- Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.Environmental Health Perspectives, 1998